Tiansheng Pharmaceutical Group Co., Ltd. (002872.SZ)
CNY 3.94
(0.77%)
CNY 3.94
(0.77%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 136.21 Million CNY | 4.08% |
| 2022 | 130.87 Million CNY | 5.05% |
| 2021 | 124.58 Million CNY | -56.83% |
| 2020 | 288.57 Million CNY | -2.39% |
| 2019 | 295.64 Million CNY | -37.09% |
| 2018 | 469.97 Million CNY | -9.42% |
| 2017 | 518.82 Million CNY | 27.09% |
| 2016 | 408.24 Million CNY | -11.52% |
| 2015 | 461.38 Million CNY | 2.8% |
| 2014 | 448.81 Million CNY | 5.73% |
| 2013 | 424.49 Million CNY | 64.58% |
| 2012 | 257.92 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 123.46 Million CNY | -4.17% |
| 2024 Q1 | 128.84 Million CNY | -5.41% |
| 2024 Q3 | 119.23 Million CNY | -3.43% |
| 2023 Q2 | 109.82 Million CNY | -13.26% |
| 2023 Q1 | 126.61 Million CNY | -3.25% |
| 2023 FY | 136.21 Million CNY | 4.08% |
| 2023 Q4 | 136.21 Million CNY | 19.6% |
| 2023 Q3 | 113.89 Million CNY | 3.7% |
| 2022 Q3 | 141.57 Million CNY | 11.09% |
| 2022 Q1 | 134.24 Million CNY | 7.75% |
| 2022 Q2 | 127.44 Million CNY | -5.07% |
| 2022 FY | 130.87 Million CNY | 5.05% |
| 2022 Q4 | 130.87 Million CNY | -7.56% |
| 2021 Q4 | 124.58 Million CNY | 2.71% |
| 2021 FY | 124.58 Million CNY | -56.83% |
| 2021 Q2 | 133.08 Million CNY | -53.63% |
| 2021 Q3 | 121.29 Million CNY | -8.86% |
| 2021 Q1 | 286.99 Million CNY | -0.55% |
| 2020 Q4 | 288.57 Million CNY | 21.7% |
| 2020 Q2 | 235.68 Million CNY | -23.8% |
| 2020 Q1 | 309.32 Million CNY | 4.63% |
| 2020 FY | 288.57 Million CNY | -2.39% |
| 2020 Q3 | 237.12 Million CNY | 0.61% |
| 2019 Q3 | 375.49 Million CNY | -11.55% |
| 2019 Q2 | 424.54 Million CNY | -3.11% |
| 2019 Q4 | 295.64 Million CNY | -21.27% |
| 2019 Q1 | 438.19 Million CNY | -6.76% |
| 2019 FY | 295.64 Million CNY | -37.09% |
| 2018 Q1 | 572.26 Million CNY | 10.3% |
| 2018 FY | 469.97 Million CNY | -9.42% |
| 2018 Q4 | 469.97 Million CNY | 2.1% |
| 2018 Q3 | 460.32 Million CNY | -6.67% |
| 2018 Q2 | 493.2 Million CNY | -13.81% |
| 2017 Q3 | 519.21 Million CNY | 36.69% |
| 2017 Q4 | 518.82 Million CNY | -0.08% |
| 2017 FY | 518.82 Million CNY | 27.09% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q2 | 379.84 Million CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q4 | 408.24 Million CNY | 0.0% |
| 2016 FY | 408.24 Million CNY | -11.52% |
| 2015 FY | 461.38 Million CNY | 2.8% |
| 2014 FY | 448.81 Million CNY | 5.73% |
| 2013 FY | 424.49 Million CNY | 64.58% |
| 2012 FY | 257.92 Million CNY | 0.0% |